The Scientific Business of Thomson Reuters Publishes Its 2008 Liquent Regulatory Affairs Trends Survey Results



    
    Survey Highlights Trends In eCTD Migration And Submissions Outsourcing And
    Provides Insights Into Regulatory Product Management Trends Across North
    America And Europe

    
    PHILADELPHIA and LONDON, July 17 /CNW/ -- The Scientific business of
Thomson Reuters today announced the early findings of its 2008 Liquent
Regulatory Affairs Trends Survey.  The survey attracted respondents from
across the globe representing small, medium and large pharmaceutical companies
and provides a unique insight into emerging and future trends in regulatory
product management usage and adoption.
    
    (Logo: http://www.newscom.com/cgi-bin/prnh/20080424/NYTH069LOGO )
    
    Now in its sixth year and frequently sourced by pharmaceutical journals
and publications across the world, this survey has become the premier
benchmark of global regulatory submission trends offering timely insights into
how pharmaceutical regulatory professionals use technology today and how they
plan to harness technology in the future.
    There were 137 Regulatory Affairs professionals working in Life Sciences
companies across the globe who participated in this survey. The survey
concentrates on four key areas: Technology Usage Trends, including both
submission publishing software and other desktop software, Document Management
System usage, Regulatory Outsourcing trends, and Regulatory trends including
use or future use of the electronic Common Technical Document (eCTD).
    The demographic make-up of the respondent population is similar to
previous years with almost one third working in large pharmaceutical companies
(32%) and more than a third working in small to medium companies (36%).
Another 10% of respondents work for biotechnology companies. There were
significantly more respondents from Contract Research Organizations (CROs) in
2008 (10%) than in 2007 (4%). 68% of those surveyed are from the United States
and the majority of the remaining respondents are from Europe, with France
(4%), Switzerland (4%), the UK (3%) and Germany (3%) the most highly
represented.

    
    Survey highlights include:
    

    
    Technology Usage:
    
    -- Almost all (92%) of the survey respondents make regulatory
submissions, a slight increase on 2007 (90%); current use of paper and
electronic submissions has remained the same since 2007.
    -- Three-quarters (75%) are using submission publishing software, similar
to 2007 (67%). Approximately one-third (31%) of those respondents not
currently using software are very likely to implement submission publishing
software into their process.
    -- As in 2007, the SAFE initiative has not yet taken hold in most
companies surveyed: only 2% of respondents are currently addressing it.
However, there has been a significant increase in the percentage of companies
that are currently using technology to support the FDA Gateway, up to 19% this
year, from 9% in 2007.


    
    Regulatory Outsourcing Trends:
    

    
    -- 30% of respondents do not outsource any of their regulatory operations.
    
    -- Printing (28%) was the regulatory operation outsourced the most by
respondents.
    
    Regulatory Trends:
    
    -- Eight in ten (83%) of respondents intend to migrate to the eCTD, with
20% of these reporting they will migrate within the next year.
    "This year's survey has once again attracted respondents from across the
breadth of the global life sciences industry, with large as well as small to
medium sized companies participating," said Jim Nichols, Liquent's Vice
President of Product Strategy and Marketing, who launched this worldwide
initiative in 2003. "We're particularly excited to see a significant increase
in the numbers of Contract Research Organizations (CROs) replying to our
survey, further diversifying the population sample."
    Full results of the survey are available on request at the following
address: http://www.liquent.com/2008survey/
    For more information about Liquent regulatory information management
services, please go to:
http://www.thomsonreuters.com/products_services/scientific1/liquentinsight
    
    About Thomson Reuters
    
    Thomson Reuters is the world's leading source of intelligent information
for businesses and professionals.  We combine industry expertise with
innovative technology to deliver critical information to leading decision
makers in the financial, legal, tax and accounting, scientific, healthcare and
media markets, powered by the world's most trusted news organization. With
headquarters in New York and major operations in London and Eagan, Minnesota,
Thomson Reuters employs more than 50,000 people in 93 countries. For more
information, go to www.thomsonreuters.com.




For further information:

For further information: Eoin Bedford of Thomson Reuters, Scientific,
+44-207-433-4691, eoin.bedford@thomsonreuters.com Web Site:
http://www.thomsonreuters.com                
http://www.liquent.com/2008survey


Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890